Panagiota Foteinou
About Panagiota Foteinou
Panagiota Foteinou is the Director of QSP Immunology at Bristol Myers Squibb in Princeton, New Jersey, with over 10 years of experience in computational and mechanistic modeling of biological systems.
Title and Current Position
Panagiota Foteinou is the Director of QSP Immunology at Bristol Myers Squibb, located in Princeton, New Jersey, United States. She currently leads the QSP immunology group, focusing on advancing quantitative systems pharmacology (QSP) modeling in pharmaceutical research and development.
Previous Positions
Panagiota Foteinou has a diverse professional background with significant experience in both academia and industry. She served as a Principal QSP Scientist at Sanofi in Bridgewater, NJ, from 2017 to 2020. Prior to that role, she was a Senior QSP Investigator at Bristol-Myers Squibb in Princeton, NJ, from 2015 to 2017. Her academic positions include postdoctoral research fellowships at Johns Hopkins University from 2012 to 2015 and the University of California, Santa Barbara from 2010 to 2012. Additionally, she worked as a Graduate Research Assistant at Rutgers University from 2005 to 2010 and as a Research Assistant at Aristotle University of Thessaloniki from 2003 to 2004.
Education and Academic Background
Panagiota Foteinou earned her Ph.D. in Biomedical Engineering from Rutgers, The State University of New Jersey-New Brunswick, where she studied from 2005 to 2010. She also holds a Dipl. Ing. Degree in Chemical Engineering from Aristoteleion Panepistimion Thessalonikis, achieved between 1999 and 2004.
Research Experience
With over 10 years of professional research experience, Panagiota Foteinou specializes in computational and mechanistic modeling of biological systems. Her research contributions include explaining biological discrepancies in literature through mathematical modeling and understanding the molecular basis of cellular arrhythmias in heart disease. Her work aims to facilitate clinical decision-making for emerging novel therapeutics.
Industry Contributions
Since 2015, Panagiota Foteinou has focused on the advancement of QSP modeling in the pharmaceutical R&D industry, specifically to support clinical decision-making for novel therapeutic interventions. At Bristol Myers Squibb, she led exploratory AI-driven projects centered on Type 2 Inflammation Research, advancing the company's capacities in translational research.